nach oben

Clinical Reviews in Allergy & Immunology

Erschienen in:

15.01.2022

Immunosenescence, Inflammaging, and Frailty: Role of Myeloid Cells in Age-Related Diseases

verfasst von: Augusto Bleve, Francesca Motta, Barbara Durante, Chiara Pandolfo, Carlo Selmi, Antonio Sica

Erschienen in: Clinical Reviews in Allergy & Immunology | Ausgabe 2/2023

Einloggen, um Zugang zu erhalten

Abstract

The immune system is the central regulator of tissue homeostasis, ensuring tissue regeneration and protection against both pathogens and the neoformation of cancer cells. Its proper functioning requires homeostatic properties, which are maintained by an adequate balance of myeloid and lymphoid responses. Aging progressively undermines this ability and compromises the correct activation of immune responses, as well as the resolution of the inflammatory response. A subclinical syndrome of “homeostatic frailty” appears as a distinctive trait of the elderly, which predisposes to immune debilitation and chronic low-grade inflammation (inflammaging), causing the uncontrolled development of chronic and degenerative diseases. The innate immune compartment, in particular, undergoes to a sequela of age-dependent functional alterations, encompassing steps of myeloid progenitor differentiation and altered responses to endogenous and exogenous threats. Here, we will review the age-dependent evolution of myeloid populations, as well as their impact on frailty and diseases of the elderly.

Foreman KJ, Marquez N, Dolgert A et al (2018) Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016–40 for 195 countries and territories. Lancet. https://doi.org/10.1016/S0140-6736(18)31694-5CrossRefPubMedPubMedCentral

da Costa JP, Vitorino R, Silva GM et al (2016) A synopsis on aging—theories, mechanisms and future prospects. Ageing Res Rev

Schmeer C, Kretz A, Wengerodt D et al (2019) Dissecting aging and senescence-current concepts and open lessons. Cells. https://doi.org/10.3390/cells8111446CrossRefPubMedPubMedCentral

Bektas A, Schurman SH, Sen R, Ferrucci L (2018) Aging, inflammation and the environment. Exp Gerontol

Franceschi C, Campisi J (2014) Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. Journals Gerontol. - Ser A Biol Sci Med Sci

Feldman N, Rotter-Maskowitz A, Okun E (2015) DAMPs as mediators of sterile inflammation in aging-related pathologies. Ageing Res Rev

Fülöp T, Larbi A, Witkowski JM (2019) Human inflammaging. Gerontology. https://doi.org/10.1159/000497375CrossRefPubMed

Sadighi Akha AA (2018) Aging and the immune system: an overview. J Immunol Methods

Motta F, Sica A, Selmi C (2020) Frailty in rheumatic diseases. Front Immunol

10.

López-Otín C, Blasco MA, Partridge L et al (2013) The hallmarks of aging. Cell

11.

Herranz N, Gil J (2018) Mechanisms and functions of cellular senescence. J Clin Invest

12.

Vicente R, Mausset-Bonnefont AL, Jorgensen C et al (2016) Cellular senescence impact on immune cell fate and function. Aging Cell

13.

Montecino-Rodriguez E, Berent-Maoz B, Dorshkind K (2013) Causes, consequences, and reversal of immune system aging. J Clin Invest

14.

Rodrigues LP, Teixeira VR, Alencar-Silva T et al (2021) Hallmarks of aging and immunosenescence: connecting the dots. Cytokine Growth Factor Rev

15.

Basisty N, Kale A, Jeon OH et al (2020) A proteomic atlas of senescence-associated secretomes for aging biomarker development. PLoS Biol. https://doi.org/10.1371/journal.pbio.3000599CrossRefPubMedPubMedCentral

16.

Goronzy JJ, Fang F, Cavanagh MM et al (2015) Naive T cell maintenance and function in human aginG. J Immunol. https://doi.org/10.4049/jimmunol.1500046CrossRefPubMed

17.

Fulop T, Larbi A, Dupuis G et al (2018) Immunosenescence and inflamm-aging as two sides of the same coin: Friends or Foes? Front Immunol

18.

Solana R, Tarazona R, Gayoso I et al (2012) Innate immunosenescence: effect of aging on cells and receptors of the innate immune system in humans. Semin Immunol

19.

Montgomery RR, Shaw AC (2015) Paradoxical changes in innate immunity in aging: recent progress and new directions. J Leukoc Biol. https://doi.org/10.1189/jlb.5mr0315-104rCrossRefPubMedPubMedCentral

20.

Hazeldine J, Lord JM (2015) Innate immunesenescence: underlying mechanisms and clinical relevance. Biogerontology

21.

Goronzy JJ, Weyand CM (2013) Understanding immunosenescence to improve responses to vaccines. Nat Immunol

22.

Franceschi C, Bonafè M, Valensin S et al (2000) Inflamm-aging. An evolutionary perspective on immunosenescence. In: Annals of the New York Academy of Sciences

23.

Kirkwood KL (2018) Inflammaging. Immunol Invest

24.

Geiger H, De Haan G, Carolina Florian M (2013) The ageing haematopoietic stem cell compartment. Nat Rev Immunol

25.

Harrison DE, Astle CM, Delaittre JA (1978) Loss of proliferative capacity in immunohemopoietic stem cells caused by serial transplantation rather than aging*. J Exp Med. https://doi.org/10.1084/jem.147.5.1526CrossRefPubMed

26.

Dorshkind K, Höfer T, Montecino-Rodriguez E et al (2020) Do haematopoietic stem cells age? Nat Rev Immunol. https://doi.org/10.1038/s41577-019-0236-2CrossRefPubMed

27.

Beerman I, Maloney WJ, Weissmann IL, Rossi DJ (2010) Stem cells and the aging hematopoietic system. Curr Opin Immunol

28.

Rossi DJ, Bryder D, Zahn JM et al (2005) Cell intrinsic alterations underlie hematopoietic stem cell aging. Proc Natl Acad Sci U S A. https://doi.org/10.1073/pnas.0503280102CrossRefPubMedPubMedCentral

29.

Pang WW, Price EA, Sahoo D et al (2011) Human bone marrow hematopoietic stem cells are increased in frequency and myeloid-biased with age. Proc Natl Acad Sci U S A. https://doi.org/10.1073/pnas.1116110108CrossRefPubMedPubMedCentral

30.

Montecino-Rodriguez E, Kong Y, Casero D et al (2019) Lymphoid-biased hematopoietic stem cells are maintained with age and efficiently generate lymphoid progeny. Stem Cell Reports. https://doi.org/10.1016/j.stemcr.2019.01.016CrossRefPubMedPubMedCentral

31.

Chambers SM, Shaw CA, Gatza C et al (2007) Aging hematopoietic stem cells decline in function and exhibit epigenetic dysregulation. PLoS Biol. https://doi.org/10.1371/journal.pbio.0050201CrossRefPubMedPubMedCentral

32.

Mittelbrunn M, Kroemer G (2021) Hallmarks of T cell aging. Nat Immunol

33.

Hagen M, Derudder E (2020) Inflammation and the Alteration of B-Cell Physiology in Aging. Gerontology

34.

Ferrucci L, Fabbri E (2018) Inflammageing: chronic inflammation in ageing, cardiovascular disease, and frailty. Nat Rev Cardiol

35.

Franceschi C, Santoro A, Capri M (2020) The complex relationship between Immunosenescence and Inflammaging: special issue on the New Biomedical Perspectives. Semin Immunopathol

36.

Franceschi C, Salvioli S, Garagnani P et al (2017a) Immunobiography and the heterogeneity of immune responses in the elderly: a focus on inflammaging and trained immunity. Front Immunol

37.

Franceschi C, Garagnani P, Vitale G et al (2017b) Inflammaging and garb-aging. Trends Endocrinol. Metab

38.

Rivera A, Siracusa MC, Yap GS, Gause WC (2016) Innate cell communication kick-starts pathogen-specific immunity. Nat Immunol

39.

Parrish AR (2017) The impact of aging on epithelial barriers. Tissue Barriers

40.

Man AL, Gicheva N, Nicoletti C (2014) The impact of ageing on the intestinal epithelial barrier and immune system. Cell Immunol

41.

Conway J, Duggal NA (2021) Ageing of the gut microbiome: potential influences on immune senescence and inflammageing. Ageing Res Rev

42.

Baylis D, Bartlett DB, Patel HP, Roberts HC (2013) Understanding how we age: insights into inflammaging. Longev Heal. https://doi.org/10.1186/2046-2395-2-8CrossRef

43.

Mantovani A, Marchesi F, Jaillon S et al (2021) Tumor-associated myeloid cells: diversity and therapeutic targeting. Cell Mol Immunol

44.

Born J, Uthgenannt D, Dodt C et al (1995) Cytokine production and lymphocyte subpopulations in aged humans. An assessment during nocturnal sleep. Mech Ageing Dev. https://doi.org/10.1016/0047-6374(95)01638-4

45.

Butcher SK, Killampalli V, Lascelles D et al (2005) Raised cortisol: DHEAS ratios in the elderly after injury: potential impact upon neutrophil function and immunity. Aging Cell. https://doi.org/10.1111/j.1474-9726.2005.00178.xCrossRefPubMed

46.

Fulop T, Larbi A, Douziech N et al (2004) Signal transduction and functional changes in neutrophils with aging. Aging Cell

47.

Sapey E, Greenwood H, Walton G et al (2014) Phosphoinositide 3-kinase inhibition restores neutrophil accuracy in the elderly: toward targeted treatments for immunosenescence. Blood. https://doi.org/10.1182/blood-2013-08-519520CrossRefPubMedPubMedCentral

48.

Niwa Y, Kasama T, Miyachi Y, Kanoh T (1989) Neutrophil chemotaxis, phagocytosis and parameters of reactive oxygen species in human aging: cross-sectional and longitudinal studies. Life Sci. https://doi.org/10.1016/0024-3205(89)90482-7CrossRefPubMed

49.

MacGregor RR, Shalit M (1990) Neutrophil function in healthy elderly subjects. Journals Gerontol. https://doi.org/10.1093/geronj/45.2.M55CrossRef

50.

Brubaker AL, Rendon JL, Ramirez L et al (2013) Reduced neutrophil chemotaxis and infiltration contributes to delayed resolution of cutaneous wound infection with advanced age. J Immunol. https://doi.org/10.4049/jimmunol.1201213CrossRefPubMed

51.

Nomellini V, Faunce DE, Gomez CR, Kovacs EJ (2008) An age-associated increase in pulmonary inflammation after burn injury is abrogated by CXCR2 inhibition. J Leukoc Biol. https://doi.org/10.1189/jlb.1007672CrossRefPubMed

52.

Wenisch C, Patruta S, Daxböck F et al (2000) Effect of age on human neutrophil function. J Leukoc Biol. https://doi.org/10.1002/jlb.67.1.40CrossRefPubMed

53.

Tseng CW, Kyme PA, Arruda A et al (2012) Innate immune dysfunctions in aged mice facilitate the systemic dissemination of methicillin-resistant S. aureus. PLoS One. https://doi.org/10.1371/journal.pone.0041454

54.

Alvarez E, Santa-María C, Ruiz-Gutiérrez V, Sobrino F (2001) Age-related changes in membrane lipid composition, fluidity and respiratory burst in rat peritoneal neutrophils. Clin Exp Immunol. https://doi.org/10.1046/j.1365-2249.2001.01490.xCrossRefPubMedPubMedCentral

55.

Fortin CF, Lesur O, Fulop T (2007) Effects of aging on triggering receptor expressed on myeloid cells (TREM)-1-induced PMN functions. FEBS Lett. https://doi.org/10.1016/j.febslet.2007.02.029CrossRefPubMed

56.

Barkaway A, Rolas L, Joulia R et al (2021) Age-related changes in the local milieu of inflamed tissues cause aberrant neutrophil trafficking and subsequent remote organ damage. Immunity

57.

De Maeyer RPH, Chambers ES (2021) The impact of ageing on monocytes and macrophages. Immunol Lett

58.

Hall BM, Balan V, Gleiberman AS et al (2016) Aging of mice is associated with p16(Ink4a)- and β-galactosidasepositive macrophage accumulation that can be induced in young mice by senescent cells. Aging (Albany NY). https://doi.org/10.18632/aging.100991

59.

van Beek AA, Van den Bossche J, Mastroberardino PG et al (2019) Metabolic alterations in aging macrophages: ingredients for inflammaging? Trends Immunol

60.

Kelly J, Khan AA, Yin J et al (2007) Senescence regulates macrophage activation and angiogenic fate at sites of tissue injury in mice. J Clin Invest. https://doi.org/10.1172/JCI32430CrossRefPubMedPubMedCentral

61.

Ogawa T, Kitagawa M, Hirokawa K (2000) Age-related changes of human bone marrow: a histometric estimation of proliferative cells, apoptotic cells, T cells, B cells and macrophages. Mech Ageing Dev. https://doi.org/10.1016/S0047-6374(00)00137-8

62.

Thevaranjan N, Puchta A, Schulz C et al (2017) Age-associated microbial dysbiosis promotes intestinal permeability, systemic inflammation, and macrophage dysfunction. Cell Host Microbe. https://doi.org/10.1016/j.chom.2017.03.002CrossRefPubMedPubMedCentral

63.

Kühn F, Adiliaghdam F, Cavallaro PM et al (2020) Intestinal alkaline phosphatase targets the gut barrier to prevent aging. JCI Insight. https://doi.org/10.1172/jci.insight.134049CrossRefPubMedPubMedCentral

64.

Wong CK, Smith CA, Sakamoto K et al (2017) Aging impairs alveolar macrophage phagocytosis and increases influenza-induced mortality in mice. J Immunol. https://doi.org/10.4049/jimmunol.1700397CrossRefPubMedPubMedCentral

65.

Li Z, Jiao Y, Fan EK et al (2017) Aging-impaired filamentous actin polymerization signaling reduces alveolar macrophage phagocytosis of bacteria. J Immunol. https://doi.org/10.4049/jimmunol.1700140CrossRefPubMedPubMedCentral

66.

Herrero C, Sebastiaán C, Marqueés L et al (2002) Immunosenescence of macrophages: Reduced MHC class II gene expression. Exp Gerontol. https://doi.org/10.1016/S0531-5565(01)00205-4CrossRefPubMed

67.

Chen H, Ma F, Hu X et al (2013) Elevated COX2 expression and PGE2 production by downregulation of RXRα in senescent macrophages. Biochem Biophys Res Commun. https://doi.org/10.1016/j.bbrc.2013.09.047CrossRefPubMedPubMedCentral

68.

Linehan E, Dombrowski Y, Snoddy R et al (2014) Aging impairs peritoneal but not bone marrow-derived macrophage phagocytosis. Aging Cell. https://doi.org/10.1111/acel.12223CrossRefPubMedPubMedCentral

69.

Alvarez E, Machado A, Sobrino F, Maria CS (1996) Nitric oxide and superoxide anion production decrease with age in resident and activated rat peritoneal macrophages. Cell Immunol. https://doi.org/10.1006/cimm.1996.0103CrossRefPubMed

70.

De Maeyer RPH, van de Merwe RC, Louie R et al (2020) Blocking elevated p38 MAPK restores efferocytosis and inflammatory resolution in the elderly. Nat Immunol. https://doi.org/10.1038/s41590-020-0646-0CrossRefPubMedPubMedCentral

71.

Mancuso P, McNish RW, Peters-Golden M, Brock TG (2001) Evaluation of phagocytosis and arachidonate metabolism by alveolar macrophages and recruited neutrophils from F344xBN rats of different ages. Mech Ageing Dev. https://doi.org/10.1016/S0047-6374(01)00322-0CrossRefPubMed

72.

Stahl EC, Brown BN (2015) Cell therapy strategies to combat immunosenescence. Organogenesis

73.

Pinhal-Enfield G, Ramanathan M, Hasko G et al (2003) An angiogenic switch in macrophages involving synergy between toll-like receptors 2, 4, 7, and 9 and adenosine A2A receptors. Am J Pathol. https://doi.org/10.1016/S0002-9440(10)63698-XCrossRefPubMedPubMedCentral

74.

Ashcroft GS, Horan MA, Ferguson MWJ (1998) Aging alters the inflammatory and endothelial cell adhesion molecule profiles during human cutaneous wound healing. Lab Investig

75.

Franceschi C, Garagnani P, Parini P et al (2018) Inflammaging: a new immune–metabolic viewpoint for age-related diseases. Nat Rev Endocrinol

76.

Potente M, Ghaeni L, Baldessari D et al (2007) SIRT1 controls endothelial angiogenic functions during vascular growth. Genes Dev. https://doi.org/10.1101/gad.435107CrossRefPubMedPubMedCentral

77.

Minhas PS, Liu L, Moon PK et al (2019) Macrophage de novo NAD+ synthesis specifies immune function in aging and inflammation. Nat Immunol. https://doi.org/10.1038/s41590-018-0255-3CrossRefPubMedPubMedCentral

78.

Consonni FM, Porta C, Marino A et al (2019) Myeloid-derived suppressor cells: ductile targets in disease. Front Immunol 10

79.

Bronte V, Brandau S, Chen SH et al (2016) Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards. Nat Commun 7

80.

Hegde S, Leader AM, Merad M (2021) MDSC: Markers, development, states, and unaddressed complexity. Immunity

81.

Enioutina EY, Bareyan D, Daynes RA (2011) A role for immature myeloid cells in immune senescence. J Immunol. https://doi.org/10.4049/jimmunol.1002987CrossRefPubMed

82.

Alves AS, Ishimura ME, de Duarte YA, O, Bueno V, (2018) Parameters of the immune system and vitamin D levels in old individuals. Front Immunol. https://doi.org/10.3389/fimmu.2018.01122CrossRefPubMedPubMedCentral

83.

Verschoor CP, Johnstone J, Millar J et al (2013) Blood CD33(+)HLA-DR(−) myeloid-derived suppressor cells are increased with age and a history of cancer. J Leukoc Biol. https://doi.org/10.1189/jlb.0912461CrossRefPubMedPubMedCentral

84.

Salminen A, Kaarniranta K, Kauppinen A (2019) Immunosenescence: the potential role of myeloid-derived suppressor cells (MDSC) in age-related immune deficiency. Cell Mol Life Sci

85.

Flores RR, Clauson CL, Cho J et al (2017) Expansion of myeloid-derived suppressor cells with aging in the bone marrow of mice through a NF-κB-dependent mechanism. Aging Cell. https://doi.org/10.1111/acel.12571CrossRefPubMedPubMedCentral

86.

Wiley CD, Velarde MC, Lecot P et al (2016) Mitochondrial dysfunction induces senescence with a distinct secretory phenotype. Cell Metab. https://doi.org/10.1016/j.cmet.2015.11.011CrossRefPubMedPubMedCentral

87.

Acosta JC, Banito A, Wuestefeld T et al (2013) A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol. https://doi.org/10.1038/ncb2784CrossRefPubMedPubMedCentral

88.

Worbs T, Hammerschmidt SI, Förster R (2017) Dendritic cell migration in health and disease. Nat Rev Immunol

89.

Jing Y, Shaheen E, Drake RR et al (2009) Aging is associated with a numerical and functional decline in plasmacytoid dendritic cells, whereas myeloid dendritic cells are relatively unaltered in human peripheral blood. Hum Immunol. https://doi.org/10.1016/j.humimm.2009.07.005CrossRefPubMedPubMedCentral

90.

Granot T, Senda T, Carpenter DJ et al (2017) Dendritic cells display subset and tissue-specific maturation dynamics over human life. Immunity. https://doi.org/10.1016/j.immuni.2017.02.019CrossRefPubMedPubMedCentral

91.

Agrawal A, Gupta S (2011) Impact of aging on dendritic cell functions in humans. Ageing Res Rev

92.

Hoogendijk EO, Afilalo J, Ensrud KE et al (2019) Frailty: implications for clinical practice and public health. Lancet

93.

Proietti M, Cesari M (2020) Frailty: what is it? In: Advances in Experimental Medicine and Biology

94.

Morley JE, Vellas B, Abellan van Kan G et al (2013) Frailty consensus: a call to action. J Am Med Dir Assoc. https://doi.org/10.1016/j.jamda.2013.03.022CrossRefPubMedPubMedCentral

95.

Pansarasa O, Pistono C, Davin A et al (2019) Altered immune system in frailty: genetics and diet may influence inflammation. Ageing Res Rev

96.

Cesari M, Nobili A, Vitale G (2016) Frailty and sarcopenia: from theory to clinical implementation and public health relevance. Eur J Intern Med

97.

Cesari M, Pérez-Zepeda MU, Marzetti E (2017) Frailty and multimorbidity: different ways of thinking about geriatrics. J Am Med Dir Assoc. https://doi.org/10.1016/j.jamda.2016.12.086CrossRefPubMedPubMedCentral

98.

Fried LP, Tangen CM, Walston J et al (2001) Frailty in older adults: evidence for a phenotype. Journals Gerontol - Ser A Biol Sci Med Sci. https://doi.org/10.1093/gerona/56.3.m146CrossRef

99.

Rockwood K, Mitnitski A (2007) Frailty in relation to the accumulation of deficits. Journals Gerontol. - Ser A Biol Sci Med Sci

100.

Villacampa-Fernández P, Navarro-Pardo E, Tarín JJ, Cano A (2017) Frailty and multimorbidity: two related yet different concepts. Maturitas

101.

Salisbury C (2012) Multimorbidity: redesigning health care for people who use it. Lancet

102.

Barnett K, Mercer SW, Norbury M et al (2012) Epidemiology of multimorbidity and implications for health care, research, and medical education: a cross-sectional study. Lancet. https://doi.org/10.1016/S0140-6736(12)60240-2CrossRefPubMed

103.

Minciullo PL, Catalano A, Mandraffino G et al (2016) Inflammaging and anti-inflammaging: the role of cytokines in extreme longevity. Arch. Immunol. Ther Exp (Warsz)

104.

Wilson D, Jackson T, Sapey E, Lord JM (2017) Frailty and sarcopenia: the potential role of an aged immune system. Ageing Res Rev

105.

Piggott DA, Varadhan R, Mehta SH et al (2015) Frailty, inflammation, and mortality among persons aging with HIV infection and injection drug use. Journals Gerontol - Ser A Biol Sci Med Sci. https://doi.org/10.1093/gerona/glv107CrossRef

106.

Soysal P, Stubbs B, Lucato P et al (2016) Inflammation and frailty in the elderly: a systematic review and meta-analysis. Ageing Res Rev

107.

Qu T, Yang H, Walston JD et al (2009) Upregulated monocytic expression of CXC chemokine ligand 10 (CXCL-10) and its relationship with serum interleukin-6 levels in the syndrome of frailty. Cytokine. https://doi.org/10.1016/j.cyto.2009.02.015CrossRefPubMedPubMedCentral

108.

Walston J, Fedarko N, Yang H et al (2008) The physical and biological characterization of a frail mouse model. Journals Gerontol - Ser A Biol Sci Med Sci. https://doi.org/10.1093/gerona/63.4.391CrossRef

109.

Fougère B, Boulanger E, Nourhashémi F et al (2017) Chronic inflammation: accelerator of biological aging. Journals Gerontol. - Ser A Biol Sci Med Sci

110.

Barbé-Tuana F, Funchal G, Schmitz CRR et al (2020) The interplay between immunosenescence and age-related diseases. Semin Immunopathol

111.

Fulop T, Witkowski JM, Olivieri F, Larbi A (2018) The integration of inflammaging in age-related diseases. Semin Immunol

112.

Veronese N (2020) Frailty as cardiovascular risk factor (and vice versa). In: Advances in Experimental Medicine and Biology

113.

Ormazabal V, Nair S, Elfeky O et al (2018) Association between insulin resistance and the development of cardiovascular disease. Cardiovasc Diabetol

114.

Libby P (2012) Inflammation in atherosclerosis. Arterioscler Thromb Vasc Biol. https://doi.org/10.1161/ATVBAHA.108.179705CrossRefPubMedPubMedCentral

115.

Fülöp T, Dupuis G, Witkowski JM, Larbi A (2016) The role of immunosenescence in the development of age-related diseases. Rev Investig Clin

116.

Soysal P, Arik F, Smith L et al (2020) Inflammation, frailty and cardiovascular disease. In: Advances in Experimental Medicine and Biology

117.

Wick G, Perschinka H, Millonig G (2001) Atherosclerosis as an autoimmune disease: an update. Trends Immunol

118.

Biasucci LM, La Rosa G, Pedicino D et al (2017) Where does inflammation fit? Curr Cardiol Rep

119.

Moore KJ, Sheedy FJ, Fisher EA (2013) Macrophages in atherosclerosis: a dynamic balance. Nat Rev Immunol 13:709–721CrossRefPubMedPubMedCentral

120.

Zeng Y, Nie C, Min J et al (2016) Novel loci and pathways significantly associated with longevity. Sci Rep. https://doi.org/10.1038/srep21243CrossRefPubMedPubMedCentral

121.

Schmidt AM (2019) Diabetes mellitus and cardiovascular disease. Arterioscler Thromb Vasc Biol

122.

Saklayen MG (2018) The global epidemic of the metabolic syndrome. Curr Hypertens Rep

123.

Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. In: Lancet

124.

Zmora N, Bashiardes S, Levy M, Elinav E (2017) The role of the immune system in metabolic health and disease. Cell Metab

125.

Salvestrini V, Sell C, Lorenzini A (2019) Obesity may accelerate the aging process. Front Endocrinol (Lausanne)

126.

Trim W, Turner JE, Thompson D (2018) Parallels in immunometabolic adipose tissue dysfunction with ageing and obesity. Front Immunol

127.

Rocha VZ, Libby P (2009) Obesity, inflammation, and atherosclerosis. Nat Rev Cardiol. https://doi.org/10.1038/nrcardio.2009.55CrossRefPubMed

128.

Hotamisligil GS, Shargill NS, Spiegelman BM (1993) Adipose expression of tumor necrosis factor-α: direct role in obesity-linked insulin resistance. Science (80- ). https://doi.org/10.1126/science.7678183

129.

Hotamisligil GS (2017) Inflammation, metaflammation and immunometabolic disorders. Nature 542:177–185CrossRefPubMed

130.

Kim HJ, Higashimori T, Park SY et al (2004) Differential effects of interleukin-6 and -10 on skeletal muscle and liver insulin action in vivo. Diabetes. https://doi.org/10.2337/diabetes.53.4.1060CrossRefPubMed

131.

Versini M, Jeandel PY, Rosenthal E, Shoenfeld Y (2014) Obesity in autoimmune diseases: Not a passive bystander. Autoimmun Rev

132.

Villareal DT, Aguirre L, Gurney AB et al (2017) Aerobic or resistance exercise, or both, in dieting obese older adults. N Engl J Med. https://doi.org/10.1056/nejmoa1616338CrossRefPubMedPubMedCentral

133.

Ferrante AW (2013) The immune cells in adipose tissue. Diabetes Obes Metab

134.

Hainer V, Aldhoon-Hainerová I (2013) Obesity paradox does exist. Diabetes Care. https://doi.org/10.2337/dcS13-2023CrossRefPubMedPubMedCentral

135.

Ahlqvist E, Storm P, Käräjämäki A et al (2018) Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables. Lancet Diabetes Endocrinol. https://doi.org/10.1016/S2213-8587(18)30051-2CrossRefPubMed

136.

Halter JB, Musi N, Horne FMF et al (2014) Diabetes and cardiovascular disease in older adults: current status and future directions. Diabetes

137.

Kahn SE, Hull RL, Utzschneider KM (2006) Mechanisms linking obesity to insulin resistance and type 2 diabetes. Nature

138.

Guarner V, Rubio-Ruiz ME (2014) Low-grade systemic inflammation connects aging, metabolic syndrome and cardiovascular disease. Interdiscip Top Gerontol. https://doi.org/10.1159/000364934CrossRefPubMed

139.

Esposito K, Nappo F, Marfella R et al (2002) Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: Role of oxidative stress. Circulation. https://doi.org/10.1161/01.CIR.0000034509.14906.AECrossRefPubMed

140.

Komura T, Sakai Y, Honda M et al (2010) CD14+ monocytes are vulnerable and functionally impaired under endoplasmic reticulum stress in patients with type 2 diabetes. Diabetes. https://doi.org/10.2337/db09-0659CrossRefPubMed

141.

Lecube A, Pachón G, Petriz J et al (2011) Phagocytic activity is impaired in type 2 diabetes mellitus and increases after metabolic improvement. PLoS One. https://doi.org/10.1371/journal.pone.0023366CrossRefPubMedPubMedCentral

142.

Panza F, Solfrizzi V, Frisardi V et al (2011) Different models of frailty in predementia and dementia syndromes. J Nutr Heal Aging. https://doi.org/10.1007/s12603-011-0126-1CrossRef

143.

Santoro A, Spinelli CC, Martucciello S et al (2018) Innate immunity and cellular senescence: the good and the bad in the developmental and aged brain. J Leukoc Biol

144.

Salter MW, Stevens B (2017) Microglia emerge as central players in brain disease. Nat Med

145.

Labzin LI, Heneka MT, Latz E (2018) Innate immunity and neurodegeneration. Annu Rev Med. https://doi.org/10.1146/annurev-med-050715-104343CrossRefPubMed

146.

Verdile G, Keane KN, Cruzat VF et al (2015) Inflammation and oxidative stress: the molecular connectivity between insulin resistance, obesity, and Alzheimer’s disease. Mediators Inflamm

147.

Rizzi L, Rosset I, Roriz-Cruz M (2014) Global epidemiology of dementia: Alzheimer’s and vascular types. Biomed Res Int. https://doi.org/10.1155/2014/908915CrossRefPubMedPubMedCentral

148.

Pizza V, Agresta A, W D’Acunto C et al (2012) Neuroinflamm-aging and neurodegenerative diseases: an overview. CNS Neurol Disord - Drug Targets. https://doi.org/10.2174/187152711796235014CrossRef

149.

Raposo C, Graubardt N, Cohen M et al (2014) CNS repair requires both effector and regulatory T cells with distinct temporal and spatial profiles. J Neurosci. https://doi.org/10.1523/JNEUROSCI.0076-14.2014CrossRefPubMedPubMedCentral

150.

Niraula A, Sheridan JF, Godbout JP (2017) Microglia priming with aging and stress. Neuropsychopharmacology

151.

Costantini E, D’Angelo C, Reale M (2018) The role of immunosenescence in neurodegenerative diseases. Mediators Inflamm

152.

Heneka MT, Carson MJ, Khoury JL et al (2015) Neuroinflammation in Alzheimer’s disease. Lancet Neurol

153.

Letiembre M, Hao W, Liu Y et al (2007) Innate immune receptor expression in normal brain aging. Neuroscience. https://doi.org/10.1016/j.neuroscience.2007.01.004CrossRefPubMed

154.

Flanary BE, Sammons NW, Nguyen C et al (2007) Evidence that aging and amyloid promote microglial cell senescence. Rejuvenation Res. https://doi.org/10.1089/rej.2006.9096CrossRefPubMed

155.

Thériault P, Elali A, Rivest S (2015) The dynamics of monocytes and microglia in Alzheimer’s disease. Alzheimer’s Res Ther

156.

Calabrese V, Santoro A, Monti D et al (2018) Aging and Parkinson’s disease: inflammaging, neuroinflammation and biological remodeling as key factors in pathogenesis. Free Radic Biol Med

157.

Salaffi F, Farah S, Carlo MD (2020) Frailty syndrome in musculoskeletal disorders: an emerging concept in rheumatology. Acta Biomed

158.

Rezuș E, Cardoneanu A, Burlui A et al (2019) The link between inflammaging and degenerative joint diseases. Int J Mol Sci

159.

Faulkner JA, Larkin LM, Claflin DR, Brooks SV (2007) Age-related changes in the structure and function of skeletal muscles. Clin Exp Pharmacol Physiol

160.

Cruz-Jentoft AJ, Baeyens JP, Bauer JM et al (2010) Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. https://doi.org/10.1093/ageing/afq034CrossRefPubMedPubMedCentral

161.

von Haehling S, Morley JE, Anker SD (2010) An overview of sarcopenia: facts and numbers on prevalence and clinical impact. J Cachexia Sarcopenia Muscle

162.

Singer M, Deutschman CS, Seymour C et al (2016) The third international consensus definitions for sepsis and septic shock (sepsis-3). JAMA - J Am Med Assoc

163.

Roh E, Choi KM (2020) Health consequences of sarcopenic obesity: a narrative review. Front Endocrinol (Lausanne)

164.

Kalinkovich A, Livshits G (2017) Sarcopenic obesity or obese sarcopenia: a cross talk between age-associated adipose tissue and skeletal muscle inflammation as a main mechanism of the pathogenesis. Ageing Res Rev

165.

Chhetri JK, de Souto Barreto P, Fougère B et al (2018) Chronic inflammation and sarcopenia: a regenerative cell therapy perspective. Exp Gerontol

166.

Jo E, Lee SR, Park BS, Kim JS (2012) Potential mechanisms underlying the role of chronic inflammation in age-related muscle wasting. Aging Clin Exp Res

167.

Beyer I, Mets T, Bautmans I (2012) Chronic low-grade inflammation and age-related sarcopenia. Curr Opin Clin Nutr Metab Care

168.

Taniguchi K, Karin M (2018) NF-B, inflammation, immunity and cancer: coming of age. Nat Rev Immunol

169.

Patsalosa A, Tzerposb P, Weia X, Nagy L (2021) Myeloid cell diversification during regenerative inflammation: lessons from skeletal muscle. Semin Cell Dev Biol S1084–9521:00114–00122

170.

Tidball JG (2017) Regulation of muscle growth and regeneration by the immune system. Nat Rev Immunol

171.

Wang Y, Welc SS, Wehling-Henricks M, Tidball JG (2018) Myeloid cell-derived tumor necrosis factor-alpha promotes sarcopenia and regulates muscle cell fusion with aging muscle fibers. Aging Cell. https://doi.org/10.1111/acel.12828CrossRefPubMedPubMedCentral

172.

Shang M, Cappellesso F, Amorim R et al (2020) Macrophage-derived glutamine boosts satellite cells and muscle regeneration. Nature. https://doi.org/10.1038/s41586-020-2857-9CrossRefPubMedPubMedCentral

173.

Laconi E, Marongiu F, DeGregori J (2020) Cancer as a disease of old age: changing mutational and microenvironmental landscapes. Br J Cancer

174.

Siegel RL, Miller KD, Jemal A (2018) Cancer statistics, 2018. CA Cancer J Clin. https://doi.org/10.3322/caac.21442CrossRefPubMedPubMedCentral

175.

Hsu T (2016) Educational initiatives in geriatric oncology – who, why, and how? J Geriatr Oncol

176.

Rea IM, Gibson DS, McGilligan V et al (2018) Age and age-related diseases: role of inflammation triggers and cytokines. Front Immunol

177.

Trinchieri G (2012) Cancer and inflammation: an old intuition with rapidly evolving new concepts. Annu Rev Immunol

178.

Coussens LM, Werb Z (2002) Inflammation and cancer. Nature

179.

Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell

180.

Cuollo L, Antonangeli F, Santoni A, Soriani A (2020) The senescence-associated secretory phenotype (Sasp) in the challenging future of cancer therapy and age-related diseases. Biology (Basel)

181.

Yang L, Li A, Lei Q, Zhang Y (2019) Tumor-intrinsic signaling pathways: key roles in the regulation of the immunosuppressive tumor microenvironment. J Hematol Oncol

182.

Lian J, Yue Y, Yu W, Zhang Y (2020) Immunosenescence: a key player in cancer development. J Hematol Oncol

183.

DeSantis CE, Miller KD, Dale W et al (2019) Cancer statistics for adults aged 85 years and older, 2019. CA Cancer J Clin. https://doi.org/10.3322/caac.21577CrossRefPubMed

184.

Hurez V, Padrón S, Svatek RS, Curiel TJ (2017) Considerations for successful cancer immunotherapy in aged hosts. Clin Exp Immunol

185.

Grizzle WE, Xu X, Zhang S et al (2007) Age-related increase of tumor susceptibility is associated with myeloid-derived suppressor cell mediated suppression of T cell cytotoxicity in recombinant inbred BXD12 mice. Mech Ageing Dev. https://doi.org/10.1016/j.mad.2007.10.003CrossRefPubMed

186.

Veglia F, Perego M, Gabrilovich D (2018) Myeloid-derived suppressor cells coming of age review-article. Nat Immunol

187.

Ostrand-Rosenberg S, Fenselau C (2018) Myeloid-derived suppressor cells: immune-suppressive cells that impair antitumor immunity and are sculpted by their environment. J Immunol. https://doi.org/10.4049/jimmunol.1701019CrossRefPubMed

188.

Aras S, Raza Zaidi M (2017) TAMeless traitors: macrophages in cancer progression and metastasis. Br J Cancer

189.

Jackaman C, Radley-Crabb HG, Soffe Z et al (2013) Targeting macrophages rescues age-related immune deficiencies in C57BL/6J geriatric mice. Aging Cell. https://doi.org/10.1111/acel.12062CrossRefPubMed

190.

Dace DS, Apte RS (2008) Effect of senescence on macrophage polarization and angiogenesis. Rejuvenation Res

191.

van Duin D, Mohanty S, Thomas V et al (2007) Age-associated defect in human TLR-1/2 function. J Immunol. https://doi.org/10.4049/jimmunol.178.2.970CrossRefPubMed

192.

Fridlender Z, Sun J, Kim S et al (2009) Polarization of tumor-associated neutrophil phenotype by TGF-beta: N1 versus N2 TAN. Cancer Cell

193.

Butcher SK, Chahal H, Nayak L et al (2001) Senescence in innate immune responses: reduced neutrophil phagocytic capacity and CD16 expression in elderly humans. J Leukoc Biol. https://doi.org/10.1189/jlb.70.6.881CrossRefPubMed

194.

Fülöp T, Fouquet C, Allaire P et al (1997) Changes in apoptosis of human polymorphonuclear granulocytes with aging. Mech Ageing Dev. https://doi.org/10.1016/S0047-6374(96)01881-7CrossRefPubMed

195.

Schröder AK, Rink L (2003) Neutrophil immunity of the elderly. In: Mechanisms of Ageing and Development

196.

Fridlender ZG, Albelda SM (2012) Tumor-associated neutrophils: friend or foe? Carcinogenesis

197.

Walker C, Mojares E, Del Río Hernández A (2018) Role of extracellular matrix in development and cancer progression. Int J Mol Sci

198.

Panwar P, Lamour G, Mackenzie NCW et al (2015) Changes in structural-mechanical properties and degradability of collagen during aging-associated modifications. J Biol Chem. https://doi.org/10.1074/jbc.M115.644310CrossRefPubMedPubMedCentral

199.

Mavrogonatou E, Pratsinis H, Papadopoulou A et al (2019) Extracellular matrix alterations in senescent cells and their significance in tissue homeostasis. Matrix Biol

200.

Zhu Y, Herndon JM, Sojka DK et al (2017) Tissue-resident macrophages in pancreatic ductal adenocarcinoma originate from embryonic hematopoiesis and promote tumor progression. Immunity 47:323-338.e6. https://doi.org/10.1016/j.immuni.2017.07.014CrossRefPubMedPubMedCentral

201.

Jiang D, Lim SY (2016) Influence of immune myeloid cells on the extracellular matrix during cancer metastasis. Cancer Microenviron

202.

McElhaney JE, Effros RB (2009) Immunosenescence: what does it mean to health outcomes in older adults? Curr Opin Immunol

203.

Liang SY (2016) Sepsis and other infectious disease emergencies in the elderly. Emerg Med Clin North Am

204.

Crooke SN, Ovsyannikova IG, Poland GA, Kennedy RB (2019) Immunosenescence and human vaccine immune responses. Immun Ageing. https://doi.org/10.1186/s12979-019-0164-9CrossRefPubMedPubMedCentral

205.

Önen NF, Agbebi A, Shacham E et al (2009) Frailty among HIV-infected persons in an urban outpatient care setting. J Infect. https://doi.org/10.1016/j.jinf.2009.08.008CrossRefPubMed

206.

Schmaltz HN, Fried LP, Xue QL et al (2005) Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women. J Am Geriatr Soc. https://doi.org/10.1111/j.1532-5415.2005.53250.xCrossRefPubMed

207.

Santesmasses D, Castro JP, Zenin AA et al (2020) COVID-19 is an emergent disease of aging. Aging Cell. https://doi.org/10.1111/acel.13230CrossRefPubMedPubMedCentral

208.

Richardson S, Hirsch JS, Narasimhan M et al (2020) Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA - J Am Med Assoc. https://doi.org/10.1001/jama.2020.6775CrossRef

209.

Verity R, Okell LC, Dorigatti I et al (2020) Estimates of the severity of coronavirus disease 2019: a model-based analysis. Lancet Infect Dis. https://doi.org/10.1016/S1473-3099(20)30243-7CrossRefPubMedPubMedCentral

210.

Fajgenbaum DC, June CH (2020) Cytokine storm. N Engl J Med. https://doi.org/10.1056/nejmra2026131CrossRefPubMedPubMedCentral

211.

Mangalmurti N, Hunter CA (2020) Cytokine storms: understanding COVID-19. Immunity

212.

Hojyo S, Uchida M, Tanaka K et al (2020) How COVID-19 induces cytokine storm with high mortality. Inflamm Regen

213.

Schulte-Schrepping J, Reusch N, Paclik D et al (2020) Severe COVID-19 is markeD by a dysregulated myeloid cell compartment. Cell. https://doi.org/10.1016/j.cell.2020.08.001CrossRefPubMedPubMedCentral

214.

Silvin A, Chapuis N, Dunsmore G et al (2020) Elevated calprotectin and abnormal myeloid cell subsets discriminate severe from milD COVID-19. Cell. https://doi.org/10.1016/j.cell.2020.08.002CrossRefPubMedPubMedCentral

215.

Szabo PA, Dogra P, Gray JI et al (2021) Longitudinal profiling of respiratory and systemic immune responses reveals myeloid cell-driven lung inflammation in severe COVID-19. Immunity. https://doi.org/10.1016/j.immuni.2021.03.005CrossRefPubMedPubMedCentral

216.

Lu Q, Liu J, Zhao S et al (2021) SARS-CoV-2 exacerbates proinflammatory responses in myeloid cells through C-type lectin receptors and Tweety family member 2. Immunity. https://doi.org/10.1016/j.immuni.2021.05.006CrossRefPubMedPubMedCentral

217.

Cavalcante-Silva LHA, Carvalho DCM, Lima É de A et al (2021) Neutrophils and COVID-19: the road so far. Int Immunopharmacol

218.

D’Alessio FR, Heller NM (2020) COVID-19 and myeloid cells: complex interplay correlates with lung severity. J Clin Invest

219.

Merad M, Martin JC (2020) Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages. Nat Rev Immunol

220.

Zhou Z, Ren L, Zhang L et al (2020) Overly exuberant innate immune response to SARS-CoV-2 infection. SSRN Electron J. https://doi.org/10.2139/ssrn.3551623CrossRef

221.

Zhang D, Guo R, Lei L et al (2021) Frontline science: COVID-19 infection induces readily detectable morphologic and inflammation-related phenotypic changes in peripheral blood monocytes. J Leukoc Biol. https://doi.org/10.1002/JLB.4HI0720-470RCrossRefPubMed

222.

Abani O, Abbas A, Abbas F et al (2021) Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial. Lancet. https://doi.org/10.1016/S0140-6736(21)00676-0CrossRef

223.

Grants JM, Wegrzyn J, Hui T et al (2020) Altered microRNA expression links IL6 and TNF-induced inflammaging with myeloid malignancy in humans and mice. Blood. https://doi.org/10.1182/blood.2019003105CrossRefPubMed

224.

Sabbatinelli J, Giuliani A, Matacchione G et al (2021) Decreased serum levels of the inflammaging marker miR-146a are associated with non-clinical response to tocilizumab in COVID-19 patients. Mech Ageing Dev. https://doi.org/10.1016/j.mad.2020.111413CrossRefPubMed

225.

Ridker PM, Everett BM, Thuren T et al (2017) Antiinflammatory therapy with canakinumab for atherosclerotic disease. N Engl J Med. https://doi.org/10.1056/nejmoa1707914CrossRefPubMed

226.

McInnes IB, Thompson L, Giles JT et al (2015) Effect of interleukin-6 receptor blockade on surrogates of vascular risk in rheumatoid arthritis: MEASURE, a randomised, placebo-controlled study. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2013-204345CrossRefPubMed

227.

Giles JT, Sattar N, Gabriel S et al (2020) Cardiovascular safety of tocilizumab versus etanercept in rheumatoid arthritis: a randomized controlled trial. Arthritis Rheumatol. https://doi.org/10.1002/art.41095CrossRefPubMedPubMedCentral

228.

Broch K, Anstensrud AK, Woxholt S et al (2021) Randomized trial of interleukin-6 receptor inhibition in patients with acute ST-segment elevation myocardial infarction. J Am Coll Cardiol. https://doi.org/10.1016/j.jacc.2021.02.049CrossRefPubMed

229.

Holte E, Kleveland O, Ueland T et al (2017) Effect of interleukin-6 inhibition on coronary microvascular and endothelial function in myocardial infarction. Heart. https://doi.org/10.1136/heartjnl-2016-310875CrossRefPubMed

230.

Alraouji NN, Al-Mohanna FH, Ghebeh H et al (2020) Tocilizumab potentiates cisplatin cytotoxicity and targets cancer stem cells in triple-negative breast cancer. Mol Carcinog. https://doi.org/10.1002/mc.23234CrossRefPubMed

231.

Ham IH, Oh HJ, Jin H et al (2019) Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer. Mol Cancer. https://doi.org/10.1186/s12943-019-0972-8CrossRefPubMedPubMedCentral

232.

Guarente L (2011) Sirtuins, aging, and metabolism. Cold Spring Harb Symp Quant Biol. https://doi.org/10.1101/sqb.2011.76.010629CrossRefPubMed

233.

Weichhart T (2018) mTOR as regulator and lifespan, aging and cellular senescence. Gerontology

234.

Pignatti C, D’adamo S, Stefanelli C et al (2020) Nutrients and pathways that regulate health span and life span. Geriatr

235.

Bjedov I, Rallis C (2020) The target of rapamycin signalling pathway in ageing and lifespan regulation. Genes (Basel)

236.

Wu Z, Isik M, Moroz N et al (2019) Dietary restriction extends lifespan through metabolic regulation of innate immunity. Cell Metab. https://doi.org/10.1016/j.cmet.2019.02.013CrossRefPubMedPubMedCentral

237.

Lee Y, Jung Y, Jeong DE et al (2021) Reduced insulin/IGF1 signaling prevents immune aging via ZIP-10/bZIP-mediated feedforward loop. J Cell Biol. https://doi.org/10.1083/jcb.202006174CrossRefPubMedPubMedCentral

238.

López-Lluch G, Navas P (2016) Calorie restriction as an intervention in ageing. J Physiol

239.

Okawa T, Nagai M, Hase K (2021) Dietary intervention impacts immune cell functions and dynamics by inducing metabolic rewiring. Front Immunol

240.

Gorbunova V, Seluanov A, Mita P et al (2021) The role of retrotransposable elements in ageing and age-associated diseases. Nature 596

Titel: Immunosenescence, Inflammaging, and Frailty: Role of Myeloid Cells in Age-Related Diseases
verfasst von: Augusto Bleve
Francesca Motta
Barbara Durante
Chiara Pandolfo
Carlo Selmi
Antonio Sica
Publikationsdatum: 15.01.2022
Verlag: Springer US
Erschienen in: Clinical Reviews in Allergy & Immunology / Ausgabe 2/2023
Print ISSN: 1080-0549
Elektronische ISSN: 1559-0267
DOI: https://doi.org/10.1007/s12016-021-08909-7

Neu im Fachgebiet HNO

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

29.05.2024 Hörstörungen Nachrichten

Hört jemand im Alter schlecht, nimmt das Hirn- und Hippocampusvolumen besonders schnell ab, was auch mit einem beschleunigten kognitiven Abbau einhergeht. Und diese Prozesse scheinen sich unabhängig von der Amyloidablagerung zu ereignen.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

16.05.2024 Pädiatrische Allergologie Nachrichten

Die große Mehrheit der vermeintlichen Penicillinallergien sind keine. Da das „Etikett“ Betalaktam-Allergie oft schon in der Kindheit erworben wird, kann ein frühzeitiges Delabeling lebenslange Vorteile bringen. Ein Team von Pädiaterinnen und Pädiatern aus Kanada stellt vor, wie sie dabei vorgehen.

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Immunosenescence, Inflammaging, and Frailty: Role of Myeloid Cells in Age-Related Diseases

Abstract

Neu im Fachgebiet HNO

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

Update HNO

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 2/2023

Inflammaging and Osteoarthritis

Allergy to Local Anesthetics is a Rarity: Review of Diagnostics and Strategies for Clinical Management

The Airway Microbiome-IL-17 Axis: a Critical Regulator of Chronic Inflammatory Disease

Inflammaging and Frailty in Immune-Mediated Rheumatic Diseases: How to Address and Score the Issue

Immunology of Aging: the Birth of Inflammaging

Real-Life Effectiveness of Benralizumab, Mepolizumab and Omalizumab in Severe Allergic Asthma Associated with Nasal Polyps

Neu im Fachgebiet HNO

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

Hörschwäche erhöht Demenzrisiko unabhängig von Beta-Amyloid

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Betalaktam-Allergie: praxisnahes Vorgehen beim Delabeling

Update HNO